NEW YORK, Jan. 8, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Integer Holdings Corporation (NYSE: ITGR). Shareholders who purchased shares of ITGR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/integer-holdings-corporation-loss-submission-form/?id=182850&from=4  CLASS P ...

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

Core Viewpoint - Rosen Law Firm is reminding purchasers of Integer Holdings Corporation common stock of the upcoming lead plaintiff deadline for a class action lawsuit related to alleged misleading statements made by the company during a specified period [1][5]. Group 1: Class Action Details - The class action pertains to investors who purchased Integer common stock between July 25, 2024, and October 22, 2025, and they may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3][5]. Group 2: Allegations Against Integer Holdings Corporation - The lawsuit claims that Integer overstated its competitive position in the electrophysiology manufacturing market and misrepresented its sales performance related to two of its EP devices [5]. - It is alleged that Integer's claims of strong visibility into customer demand were false, and the company mischaracterized its EP devices as a long-term growth driver for its cardio and vascular segment [5]. - The lawsuit asserts that the positive statements made by the defendants regarding Integer's business and prospects were materially false and misleading, leading to investor damages when the truth was revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been recognized for its performance in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013, recovering hundreds of millions for investors [4].

NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: http ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integer Holdings Corporation during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Integer common stock between July 25, 2024, and October 22, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Integer Holdings Corporation made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market and mischaracterized its EP devices as growth drivers [5]. - It is claimed that Integer experienced a deterioration in sales for two of its EP devices, contradicting its public statements about strong customer demand [5].

Core Viewpoint - A class action has been initiated against Integer Holdings Corporation, alleging that the company made false statements regarding its competitive position and sales performance in the electrophysiology manufacturing market during the specified class period from July 25, 2024, to October 22, 2025 [1][3]. Group 1: Legal Action - The Portnoy Law Firm is representing investors who purchased securities during the class period and encourages them to file a lead plaintiff motion by February 9, 2026 [1]. - Investors can contact attorney Lesley F. Portnoy for a complimentary case evaluation and to discuss options for recovering losses [2]. Group 2: Allegations Against the Company - The complaint alleges that Integer materially overstated its competitive position within the electrophysiology manufacturing market [3]. - It is claimed that despite Integer's assertions of strong visibility into customer demand, the company was experiencing a sustained deterioration in sales related to two of its electrophysiology devices [3]. - The company mischaracterized its electrophysiology devices as a long-term growth driver for its cardio & vascular segment, leading to materially false and misleading statements about its business and prospects [3].

NEW YORK, Jan. 2, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: http ...

Core Viewpoint - Integer Holdings Corporation (NYSE: ITGR) is facing allegations of issuing materially false and misleading statements regarding its competitive position and sales performance in the electrophysiology manufacturing market during the class period from July 25, 2024, to October 22, 2025 [3]. Group 1: Allegations - The complaint alleges that Integer overstated its competitive position within the growing electrophysiology manufacturing market [3]. - Despite claims of strong visibility into customer demand, Integer was experiencing a sustained deterioration in sales related to two of its electrophysiology devices [3]. - Integer mischaracterized its electrophysiology devices as a long-term growth driver for the cardio & vascular segment [3]. - Positive statements made by the defendants about the Company's business, operations, and prospects were materially false and misleading or lacked a reasonable basis [3]. Group 2: Class Action Details - Shareholders who purchased shares of ITGR during the specified class period are encouraged to contact the Gross Law Firm regarding possible lead plaintiff appointment [1]. - The deadline for shareholders to seek to be a lead plaintiff is February 9, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integer Holdings Corporation during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Integer common stock between July 25, 2024, and October 22, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Integer Holdings Corporation made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market and the performance of its EP devices [5]. - It is claimed that Integer misrepresented its EP devices as a long-term growth driver, leading to misleading positive statements about its business and operations [5].

Core Insights - Intelligent Bio Solutions Inc. (INBS) has formed a strategic manufacturing partnership with Syrma Johari MedTech to enhance its production capabilities and support its entry into the U.S. market in 2026 [1][3]. Group 1: Partnership Benefits - The partnership is expected to yield annual production cost savings exceeding 40%, leading to an anticipated improvement of approximately 20 percentage points in gross margin compared to previous manufacturing arrangements [2]. - Syrma Johari's manufacturing capacity is about four times that of INBS, enabling the company to efficiently meet anticipated demand as it scales its commercial operations [2]. Group 2: Supply Chain Resilience - This collaboration strengthens INBS' global manufacturing strategy by reducing reliance on a single supplier and enhancing supply chain resilience [3]. - The partnership broadens manufacturing capacity, ensures continuity, and creates flexibility in preparation for future demand across multiple regions [3]. Group 3: Syrma Johari's Capabilities - Syrma Johari has over 45 years of experience in medical device engineering and manufacturing, operating 14 manufacturing locations and four design and innovation centers globally [4]. - The company is certified to ISO 13485, MDSAP, FDA, TUV SUD, and GMP standards, ensuring high compliance and quality in medical device manufacturing [4]. Group 4: Production Efficiency - Syrma Johari's vertical integration and export-oriented model facilitate high-quality production while optimizing sourcing, tooling, testing, and logistics [5]. - The company is set to open a new medical-grade plastics manufacturing facility in India in January 2026, further enhancing its capabilities to meet global demand [5]. Group 5: Regulatory Support - Syrma Johari's extensive regulatory and quality-assurance capabilities align with INBS' global expansion plans, providing end-to-end quality systems and regulatory documentation support [6]. - This expertise will assist INBS in advancing its regulatory pathways and preparing for increased commercial activity worldwide [6]. Group 6: Strategic Importance - The partnership is viewed as a significant milestone for INBS, enhancing its supply chain and supporting future growth [7]. - Both companies express a strong alignment in innovation, quality, and long-term vision, indicating a commitment to scaling disruptive drug-screening technology [7][8].